SARS-CoV-2 in Peritoneal Fluids. Our Point of View after a Short Review of Literature
Journal Title: Journal of Surgery Research and Practice - Year 2021, Vol 2, Issue 3
Abstract
One of the most interesting topics concerning SARS-CoV-2 infection is about the theoretical transmission of the virus during surgery. The virus is transmitted mainly through respiratory droplets containing the viral particles: these are usually exhaled by the infected subject when coughing, sneezing or simply talking and the amount of viral particles released is greater as the infection process goes one. Regardless the gastrointestinal involvement in the case of infection, that may be present in different percentages of cases (12.5% in our cohort of patients), any kind of invasive approach could hypothetically cause the aerosolization of viral particles and potentially lead to the contamination of the operating room [1-3]. In this respect, recent studies have focused on the unknown role covered by some invasive procedures like laparoscopic surgery: Seeliger, et al., reported the absence of viral RNA in the peritoneal samples of 5 patients, analyzed throughout RT-PCR assay; also an Indian study by Gaba, et al., on 11 biological samples from 8 patients (7 wound swabs, 2 peritoneal fluids and 2 tissue specimens) did not identify the viral genome in any of the samples considered [1,2]. Similar results were recorded in an interesting work by a group of polish researchers on 65 peritoneal samples in pregnant women tested positive for SARS-CoV-2 infection and in another study from Bahrain on 5 peritoneal samples, all tested negative for the viral detection. The potential role of peritoneal swabs in the alternative detection of SARS-CoV-2 RNA during surgery is a point of discussion in the current literature but the amount of studies concerning this topic is still too small to get to any kind of conclusion [4]. We discussed about the reliability of peritoneal tests in one of our previous works dedicated to this particular aspect of the disease concluding that caution is still required in case of surgery with COVID-19 inpatients; moreover, the current literature does not allow to understand whether handling biological fluids of such patients is completely safe or not and much attention should be provided during either invasive or mini-invasive procedures [5]. Based on the studies cited above, it would seem that peritoneal fluids are somehow spared from viral penetration, but for all the intrinsic limitations of these findings and the small size of the samples considered, further specific studies are still needed in order to define the actual role of biological fluids’ samples.
Authors and Affiliations
Salvatore Greco, Nicolò Fabbri
Retrograde Insertion of Inferior Vena Cava (IVC) Filter: A Bailout Plan
Venous thromboembolism poses a significant threat to patient health and remains a leading cause of preventable morbidity and mortality. To mitigate the risk of pulmonary embolism resulting from deep vein thrombosis, the...
Palliative Bilio-Digestive Anastomosis for the Treatment of Bile Duct Obstruction Due to Pancreatic Head Tumors: Techniques and Therapeutic Results
Introduction: Biliary-digestive anastomosis are a fistulization between the bile ducts and the digestive tract that aims at permanent drainage of bile to the digestive tract in case of obstruction at the lower bile duc...
A Case of Simultaneous Resection of Recurrent Colorectal Liver Metastases as part of Colorectal Cancer Treatment Journey
Combining systemic treatments with liver resection in patients with colorectal liver metastases has been proven to be successful in delivering favorable survival outcomes. We describe a 68-year-old man who underwent six...
Neonatal Crohn’s Disease Caused by Compound Homozygous Mutation in IL-10RA: A Case Report
Very Early-Onset Inflammatory Bowel Disease (VEO-IBD) and infantile IBD occur in children aged less than six years and younger than two years, respectively. Since childhood-onset IBD seems to be a more aggressive and rap...
Central Shunting for Tetralogy of Fallot After Original Blalock-Taussig Shunt in a 34-Year-Old Woman
The Blalock-Taussig (BT) shunt was first used to treat the tetralogy of Fallot in 1946. Since then, it has undergone improvements to create a short circuit in the pulmonary artery using an artificial blood vessel. The pr...